rheumatoid-arthritis

Documents about rheumatoid-arthritis

• Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)#888220ClinicalTrials.gov
• Temporomandibular Joint in Patients With Rheumatoid Arthritis#899389ClinicalTrials.gov
• The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis#909809ClinicalTrials.gov
• Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis#911764ClinicalTrials.gov
• Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis#979881ClinicalTrials.gov
• Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting#981588ClinicalTrials.gov
• A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis#993871ClinicalTrials.gov
• Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis#994428ClinicalTrials.gov
• Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France#1008103ClinicalTrials.gov
• National and subnational burden and attributable risk factors of osteoarthritis, rheumatoid arthritis, and low back pain in Iran: 1990–2019 findings of the Global Burden of Disease (GBD) Study#345372PLOS
• A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015K#813983ClinicalTrials.gov
• Efficacy and Safety of Luo-Fu-Shan Plaster in Patients With Rheumatoid Arthritis#865724ClinicalTrials.gov
• A Comparison of Two Electronic Gloves in the Measurement of Joint Movement in Patients With Rheumatoid Arthritis#1008977ClinicalTrials.gov
• Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)#905415ClinicalTrials.gov
• An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants#902455ClinicalTrials.gov
• The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients#283216ClinicalTrials.gov
• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis#290939ClinicalTrials.gov
• Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis#387293ClinicalTrials.gov
• Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis#812810ClinicalTrials.gov
• A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate#843972ClinicalTrials.gov
• ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate#850576ClinicalTrials.gov
• Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis#855202ClinicalTrials.gov
• Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins#864431ClinicalTrials.gov
• Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate#872288ClinicalTrials.gov
• Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid Arthritis#885996ClinicalTrials.gov
• Study of the Articular Microbiota in Rheumatoid Arthritis.#889563ClinicalTrials.gov
• A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis#889892ClinicalTrials.gov
• Remission and Joint Damage Progression in Early Rheumatoid Arthritis#892933ClinicalTrials.gov
• Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis#895499ClinicalTrials.gov
• Patient Outcomes: Real World Evidence in Rheumatoid Arthritis (POWER)#895681ClinicalTrials.gov
• Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)#897980ClinicalTrials.gov
• Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)#898553ClinicalTrials.gov
• Effect Of Moringa Leaf Extract On Disease Activity In Rheumatoid Arthritis Patients#901611ClinicalTrials.gov
• A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis#908243ClinicalTrials.gov
• Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis#917623ClinicalTrials.gov
• A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis#969855ClinicalTrials.gov
• Correlation Between Beliefs About Medicine and Objective Measures of Efficacy and Safety in Rheumatoid Arthritis (RA)#979603ClinicalTrials.gov
• APART Advanced Profiling of Anti-Rheumatic Therapies#981252ClinicalTrials.gov
• Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis#1009731ClinicalTrials.gov
• Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.#828765ClinicalTrials.gov
• The Efficacy of the Traditional Chinese Medicine Niubang Pill Combined With Methotrexate on Active Rheumatoid Arthritis#899587ClinicalTrials.gov
• Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA#900352ClinicalTrials.gov
• Gut microbiota in early and established stages of rheumatoid arthritis: from pathogenesis to promising prevention and treatment#4708Europe PMC
• Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)#900953ClinicalTrials.gov
• Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis#909177ClinicalTrials.gov
• Fatigue in rheumatoid arthritis#447201University of Nottingham Repository
• Adipokines as Predictors of Foot Function, Pain, and Disability in Patients With Rheumatoid Arthritis#448213ClinicalTrials.gov
• Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics#807671ClinicalTrials.gov
• Factors Affecting Hand Dysfunction in Patient With Rheumatoid Arthritis and Its Correlation With Quality of Life#808035ClinicalTrials.gov
• Evaluation of Non-surgical Periodontal Therapy in Patients With Rheumatoid Arthritis#825898ClinicalTrials.gov